Skip to Main Content
Title
Economic consequences for Medicaid of human immunodeficiency virus infection.
First Author
Baily, Mary A
Date of Pub
1990 Supp.
Pages
97-108
Volume
Supp.
Issue
N/A
Other Authors
Bilheimer, Linda; Greenberg, Warren; Langwell, Kathryn M; Wooldridge, Judith
Abstract
Medicaid is currently a major source of financing for health care for those with acquired immunodeficiency syndrome (AIDS) and to a lesser extent, for those with other manifestations of human immunodeficiency virus (HIV) infection. It is likely to become even more important in the future. This article focuses on the structure of Medicaid in the context of the HIV epidemic, covering epidemiological issues, eligibility, service coverage and use, and reimbursement. A simple methodology for estimating HIV-related Medicaid costs under alternative assumptions about the future is also explained.
Abstract Continued
N/A
MeSH
Acquired Immunodeficiency Syndrome/economics : Adult : Costs and Cost Analysis/statistics & numerical data : Disease Outbreaks/economics : HIV Infections/economics : Human : Insurance, Health/utilization : Male : Medicaid/utilization : Support, U.S. Gov't, Non-P.H.S. : United States : United States Health Care Financing Administration
NTIS Number
PB91-176248